Universe Pharmaceuticals (UPC) Competitors $0.20 +0.06 (+41.33%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.18 -0.03 (-12.61%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends UPC vs. PTEIQ, ENVB, EVFM, NMTR, ADTX, VIRX, BIOR, BDRX, PRFX, and SRNEShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include PolarityTE (PTEIQ), Enveric Biosciences (ENVB), Evofem Biosciences (EVFM), 9 Meters Biopharma (NMTR), Aditxt (ADTX), Viracta Therapeutics (VIRX), Biora Therapeutics (BIOR), Biodexa Pharmaceuticals (BDRX), PainReform (PRFX), and Sorrento Therapeutics (SRNE). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. PolarityTE Enveric Biosciences Evofem Biosciences 9 Meters Biopharma Aditxt Viracta Therapeutics Biora Therapeutics Biodexa Pharmaceuticals PainReform Sorrento Therapeutics PolarityTE (NASDAQ:PTEIQ) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Which has stronger valuation & earnings, PTEIQ or UPC? Universe Pharmaceuticals has higher revenue and earnings than PolarityTE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarityTE$810K1.35-$7.83M-$3.28-0.05Universe Pharmaceuticals$32.31M0.01-$6.16MN/AN/A Does the media refer more to PTEIQ or UPC? In the previous week, PolarityTE's average media sentiment score of 0.00 equaled Universe Pharmaceuticals'average media sentiment score. Company Overall Sentiment PolarityTE Neutral Universe Pharmaceuticals Neutral Is PTEIQ or UPC more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat PolarityTE's return on equity.Company Net Margins Return on Equity Return on Assets PolarityTEN/A -106.08% -76.91% Universe Pharmaceuticals N/A N/A N/A Does the MarketBeat Community prefer PTEIQ or UPC? PolarityTE and Universe Pharmaceuticals both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPolarityTEN/AN/AUniverse PharmaceuticalsN/AN/A Which has more risk and volatility, PTEIQ or UPC? PolarityTE has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Do insiders & institutionals hold more shares of PTEIQ or UPC? 11.8% of PolarityTE shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 5.4% of PolarityTE shares are held by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryUniverse Pharmaceuticals beats PolarityTE on 6 of the 8 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$240,000.00$7.07B$5.85B$20.34BDividend YieldN/A2.76%4.76%3.64%P/E RatioN/A2.5616.5128.66Price / Sales0.01304.55450.0215.49Price / CashN/A65.6738.0120.33Price / Book0.006.717.644.80Net Income-$6.16M$138.11M$3.18B$1.02B7 Day Performance22.06%-2.54%-1.95%-1.05%1 Month Performance-58.95%-2.00%-0.23%-1.09%1 Year Performance-99.22%-5.04%16.69%13.70% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$0.20+41.3%N/A-99.2%$240,000.00$32.31M0.00220Gap DownHigh Trading VolumePTEIQPolarityTEN/A$0.15flatN/A+49.3%$1.09M$810,000.00-0.0560ENVBEnveric Biosciences0.9391 of 5 stars$1.60+0.6%N/A-89.4%$1.09MN/A-0.0420EVFMEvofem BiosciencesN/A$0.01+3.3%N/A-65.9%$1.08M$18.22M-0.02120Gap UpNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220ADTXAditxt0.9193 of 5 stars$0.07-6.5%N/A-99.9%$996,000.00$640,000.000.0060News CoverageGap DownHigh Trading VolumeVIRXViracta Therapeutics2.8999 of 5 stars$0.02+1.2%$4.05+23,584.2%-94.7%$680,000.00N/A-0.0220BIORBiora Therapeutics1.9981 of 5 stars$0.12-22.0%$23.00+18,675.5%-98.5%$554,000.00$892,000.00-0.01120Gap DownBDRXBiodexa Pharmaceuticals0.7148 of 5 stars$4.27-11.8%N/AN/A$512,000.00$470,000.000.0020Gap DownHigh Trading VolumePRFXPainReform1.9988 of 5 stars$2.82-2.8%$8.00+183.7%-60.5%$395,000.00N/A-0.024Gap DownSRNESorrento TherapeuticsN/A$0.00-84.2%N/A-98.1%$331,000.00$62.84M0.00800Analyst ForecastGap Down Related Companies and Tools Related Companies PTEIQ Alternatives ENVB Alternatives EVFM Alternatives NMTR Alternatives ADTX Alternatives VIRX Alternatives BIOR Alternatives BDRX Alternatives PRFX Alternatives SRNE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:UPC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPC Stock Alerts